Start-up stories: From science to business

Their first pitch deck didn’t contain a business slide. And there wasn’t any information on market potential. These were things that Dr Isabel Schellinger and Dr Uwe Raaz simply hadn’t thought of. After all, their focus was on their research, on the amazing opportunities made possible thanks to science, and on a medical solution to an aortic disorder in humans that they had developed. This is their passion and their field of expertise. Pitching to investors and founding a start-up were things that they first needed to learn.

Today, the two of them are successfully running their medtech start-up Angiolutions, a HTGF portfolio company that was founded in 2020 in the middle of the pandemic. The two doctors conducted research together at Stanford. Building on their research work, they came up with the idea of a novel vascular implant to treat aortic aneurysms. The aorta plays an absolutely vital role, carrying oxygen-rich blood from the heart to the rest of the body. It has a diameter of 2.5 to 3.5cm. If the aorta becomes enlarged and then bulges, it can present a major risk. This is known as an aneurysm. If the aorta tears or bursts, it can be life-threatening. A bulging aorta is like a ticking time bomb, with its diameter increasing by around 2.5mm per year. Around 4-8 percent of men around the world suffer from abdominal aortic aneurysms.

Thanks to Angiolutions’s device-based therapy, doctors now for the first time have access to a minimally invasive, low-risk treatment option that prevents small aortic aneurysms from growing in size.

In this episode of our “Start-up stories” series of short videos, Dr Isabel Schellinger and Dr Uwe Raaz tell us about their journey into the world of business and offer some tips on founding a start-up in the field of science. Here’s a little teaser of what they have to say: As is so often the case, the key is to identify a genuine medical need or a genuine customer need. Get support from good partners. And don’t forget to put a business slide in your pitch deck.

A big thank you to Isabel and Uwe for all their insights!

Are you a medtech entrepreneur or looking to found a start-up in this field? Share your experiences and ideas with Principal Anke Caßing. She looks forward to hearing from you.

More Blog posts

18. September 2023

The best network is an active one – how HTGF supports C-level recruitment

For every company, finding access to specialized expertise and especially finding the perfect individual to complement a team can be a lengthy and resource-intensive search. This is where the HTGF can offer excellent support, thanks to its extensive network. It connects those who are seeking with those who are offering. For nearly three years, these threads have come together through Christina Siebel, Senior HR Relationship Manager. With over 15 years of professional experience in human reso
15. September 2023

Generation Greentech: How young ideas change the world

Five quick questions for Daniela Bach, Senior Investment Manager HTGF and Christian-Hauke Poensgen, Co-Founder Maya Climate Christian-Hauke Poensgen, Co-Founder, Maya Climate and Daniela Bach, Senior Investment Manager, HTGF What is Maya Climate and why can your idea make the world a little better? Christian-Hauke Poensgen: We are a financing platform for nature-based solutions (NbS). These are some of the most efficient and scalable solutions for avoiding and reducing carbon in
Frank Hensel HTGF
15. August 2023

Investments in drug development: “We need to get to the source of the deals”

Dr. Frank Hensel is Principal at High-Tech Gründerfonds (HTGF), where he is primarily responsible for start-ups from the field of drug development. Before joining HTGF, he was a successful entrepreneur himself and is now able to share his practical experience with start-ups. We sat down for a chat with him about the challenges of the sector, how HTGF is on the lookout for new innovations and why partnerships are especially important in this field. Frank, your investments are focused